Announcement under Regulation 30 (LODR)-Acquisition
30-May-2026 | Source : BSEPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended and read with schedule III of aforesaid regulations dated 30 January 2026 the Board of Directors of the Company in their meeting held on 29 May 2026 has inter alia approved the incorporation of a wholly owned subsidiary by the name Earkart Pharmaceuticals Private Limited and Earkart Healthcare Services Private Limited.
Declaration Pursuant To Regulation 33(3)(D) Of The SEBI(Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended In Respect Of Audit Report With Unmodified Opinion For The Financial Year Ended 31 March 2026
29-May-2026 | Source : BSEThe statutory auditor of the Company M/s Timsi & Associates Chartered Accountants has issued Audit Report with unmodified opinion on the Audited Fiancial Results of the Company for the half yearly ended and yearly ended 31 March 2026.
Board Meeting Outcome for Outcome Of Board Meeting Dated 29 May 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015
29-May-2026 | Source : BSEThe Board of Directors of the Earkart Limited at its meeting held on 29 May 2026 inter alia considered and approved Audited Financial Results for the half year ended and financial year ended 31 March 2026 along with Independent Auditors Report issued by the statutory auditors M/s Timsi & Associates
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






